Today is a major milestone for Lyrebird Health as we announce our $12 million in our first venture round - and share more broadly the mission that’s guided us from day one.
Lyrebird began with a doctor, a patient, and a waitlist.
It started when I was waiting to see a specialist when I learned that the wait time would be over 12 months. Surprised, I asked this GP why. The answer? My doctor was spending hours each day on paperwork instead of seeing patients. That conversation was the spark. I realised the issue wasn’t just demand — it was inefficiency. And I believed patients deserved better. So did doctors.
From that seed, Lyrebird was born: a way to use AI to free up clinicians' time, reduce burnout, and ultimately help more people get the care they need, faster.
Since launch, thousands of clinicians have joined us on this journey. They’ve told us what matters most — safe, reliable tools they can trust. Tools that integrate seamlessly into their workflow. Tools that make clinical practice better.
We’ve listened. And we’ve built.
Lyrebird Health is the most widely used AI scribe for Australian General Practitioners. Since May 2023, we’ve now grown to over 28,000 patient consults a day, launched deep integrations with leading EMRs (like Best Practice and Gentu), and supported the care of tens of thousands of patients. Every day, doctors bring Lyrebird into their consult rooms — and trust us to support the most important conversations in healthcare.
Since launching, the experiences and feedback has shown us that the industry is ready for more and encourages us to continue on this path. That’s why, as of today, we’re ecstatic to share with the world that Lyrebird has closed a $12 million venture round. Led from Five V Capital and UK-based Octopus Ventures with participation from Startmate.
There are so many people we are indebted to for their advice, support and advocacy they have given, but in particular our community and our team who have been there from day one. 👏
Raising our first venture round is a testament of the customer’s belief in Lyrebird Health.
This funding helps us take the next step in transforming the future of patient care — at scale. We’re building for the long term, and we take seriously the trust clinicians place in us. With this raise, we’ll deepen our investment in product quality, privacy, and safety. We’re also expanding internationally, beginning with the UK and a partnership with King’s Hospital in Dubai.
Lyrebird is built in close partnership with clinicians, and that will never change. Every feature, every integration, every decision — we build it with and for the doctors and healthcare teams who use it.
As we continue building, it’s important to us that Lyrebird remains:
We’re here for the long haul. And we believe this technology — when designed with care and intention — will enable clinicians to work twice as efficiently, reduce burnout, and improve care for everyone.
To the doctors who’ve helped shape Lyrebird so far: thank you. To those we haven’t met yet: we’re ready when you are.
With deep gratitude and excitement for what’s ahead.
Kai
